Loading…
MBX Biosciences, Inc. is projected to rise to $104.40 by 2027, a +57% move from its current price of $66.46. MBX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $63.83 | $66.48 | $69.23 | +0.03% |
| Aug 2 | $62.79 | $66.50 | $70.43 | +0.06% |
| Aug 3 | $62.00 | $66.52 | $71.36 | +0.08% |
| Aug 4 | $61.35 | $66.53 | $72.16 | +0.11% |
| Aug 5 | $60.78 | $66.55 | $72.87 | +0.14% |
| Aug 6 | $60.27 | $66.57 | $73.53 | +0.17% |
| Aug 7 | $59.81 | $66.59 | $74.14 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $59.81 | $66.59 | $74.14 | +0.19% |
| Week 2 | $57.32 | $66.72 | $77.66 | +0.39% |
| Week 3 | $55.50 | $66.85 | $80.51 | +0.58% |
| Week 4 | $54.03 | $66.98 | $83.02 | +0.78% |
| Week 5 | $52.78 | $67.10 | $85.32 | +0.97% |
| Week 6 | $51.68 | $67.23 | $87.46 | +1.17% |
| Week 7 | $50.70 | $67.36 | $89.50 | +1.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision peptide therapies for endocrine and metabolic disorders. Its lead product candidate is Canvuparatide (MBX 2109), a parathyroid hormone peptide prodrug, which is in Phase 3 clinical trial for the treatment of chronic hypoparathyroidism.
It is also developing Imapextide (MBX 1416), a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 2 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.
MBX Biosciences, Inc. is currently trading at $66.46 per share with a market capitalization of $3.16B and a rank of 1592. The stock sits in a bullish technical context, supported by a 30-day price frame and near-term momentum.
A major floor 59.5% below — a decisive break under it would weaken the trend.
The nearest floor, 37.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 24.9% above — clearing it would confirm fresh momentum.
Key MBX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MBX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $62.76 | Buy | $63.43 | Buy |
| MA 10 | $61.90 | Buy | $62.11 | Buy |
| MA 20 | $61.03 | Buy | $59.31 | Buy |
| MA 50 | $47.17 | Buy | $50.96 | Buy |
| MA 100 | $39.28 | Buy | $43.60 | Buy |
| MA 200 | $34.70 | Buy | $36.10 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.74 | Neutral |
| Stoch RSI (14) | 59.21 | Neutral |
| CCI (20) | 177.40 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.43 | Sell |
| ROC (12) | 17.44 | Buy |
| Bollinger %B (20,2) | 1.03 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.38 | Buy |
| Awesome (5,34) | 7.95 | Buy |
| Ultimate (7,14,28) | 65.09 | Neutral |
| Momentum (10) | 8.14 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 63.67 | Buy |
| ADX (14) | 34.46 | Buy |
| ATR (14) | 2.29 | Info |
The 30-day technical picture is bullish, with RSI14 at 70.0. The stock trades above the SMA50 of $47.17 and the SMA200 of $34.70, indicating constructive momentum. Immediate support sits at $41.59 and resistance at $66.46, framing a defined range within which prices have recently moved.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $26.92 | $66.46 | $93.39 | 0% | Neutral | |
| $79.57 | $104.40 | $146.84 | +57% | Bullish | |
| $78.57 | $107.76 | $159.69 | +62% | Bullish | |
| $83.93 | $119.45 | $184.27 | +80% | Bullish | |
| $95.28 | $140.17 | $223.56 | +111% | Bullish | |
| $96.08 | $145.72 | $239.21 | +119% | Bullish | |
| $123.10 | $192.14 | $323.60 | +189% | Bullish | |
| $152.10 | $243.97 | $420.47 | +267% | Bullish | |
| $163.42 | $269.06 | $473.60 | +305% | Bullish | |
| $179.16 | $302.51 | $542.96 | +355% | Bullish | |
| $279.24 | $530.54 | $1,032.19 | +698% | Bullish | |
| $396.01 | $880.01 | $1,920.35 | +12.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $26.92 | $66.46 | $77.65 | +0.00% |
| August 2026 | $54.97 | $65.19 | $79.59 | -1.92% |
| September 2026 | $56.76 | $68.15 | $84.85 | +4.55% |
| October 2026 | $58.24 | $70.65 | $89.31 | +3.66% |
| November 2026 | $57.16 | $69.91 | $89.48 | -1.04% |
| December 2026 | $58.54 | $72.16 | $93.39 | +3.21% |
Click any year to see its month-by-month MBX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MBX price prediction for 2026 points to an average of $66.46 (low $26.92, high $93.39) — a potential gain of 0% on today's $66.46. Price action looks broadly range-bound.
In 2027, MBX is projected to trade between $79.57 and $146.84, averaging $104.40 — a potential gain of +57% from today's $66.46. That is up +57% on the projected 2026 average. Buyers look set to stay in control over this stretch.
MBX Biosciences, Inc.'s 2028 outlook centres on $107.76, within a $78.57 to $159.69 range. That is up +3% on the projected 2027 average. That marks a +62% change versus current levels. Momentum favours further upside here.
By 2029, MBX could reach as high as $184.27, with a base case around $119.45 and support toward $83.93 — roughly +80% from $66.46. Buyers look set to stay in control over this stretch.
Expect MBX to range from $95.28 to $223.56 through 2030. The $140.17 average target implies a +111% move from current prices. That is up +17% on the projected 2029 average. Momentum favours further upside here.
The MBX price prediction for 2031 points to an average of $145.72 (low $96.08, high $239.21) — a potential gain of +119% on today's $66.46. Buyers look set to stay in control over this stretch.
In 2032, MBX is projected to trade between $123.10 and $323.60, averaging $192.14 — a potential gain of +189% from today's $66.46. That is up +32% on the projected 2031 average. Momentum favours further upside here.
MBX Biosciences, Inc.'s 2033 outlook centres on $243.97, within a $152.10 to $420.47 range. That is up +27% on the projected 2032 average. That marks a +267% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, MBX could reach as high as $473.60, with a base case around $269.06 and support toward $163.42 — roughly +305% from $66.46. Momentum favours further upside here.
Expect MBX to range from $179.16 to $542.96 through 2035. The $302.51 average target implies a +355% move from current prices. That is up +12% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The MBX price prediction for 2040 points to an average of $530.54 (low $279.24, high $1,032.19) — a potential gain of +698% on today's $66.46. Momentum favours further upside here.
In 2050, MBX is projected to trade between $396.01 and $1,920.35, averaging $880.01 — a potential gain of +12.2x from today's $66.46. That is up +66% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MBX today (≈ 15.046645 MBX) could be worth
$13,241.25
+$12,241.25 (+1224%) by 2050 · US Dollar
Based on the average projected MBX price of $880.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MBXwould be worth at today's price.
$1,000 invested in MBX on Jul 30, 2025 (≈ 64.55778 MBX) would be worth
$4,290.51
+$3,290.51 (+329.1%) today · 4.29× · US Dollar
Based on a MBX entry price of $15.49 vs. today's $66.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $63.57 | $1,045.46 | +4.5% |
| 1 month ago | $55.2 | $1,203.99 | +20.4% |
| 3 months ago | $29.78 | $2,231.7 | +123.2% |
| 6 months ago | $36.85 | $1,803.53 | +80.4% |
| 1 year ago | $15.49 | $4,290.51 | +329.1% |
| All time (1.9y) ago | $23.65 | $2,810.15 | +181.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MBX forecast.
Our base-case forecast reaches $130.00 around 2030.
Implied market cap at $130.00: $6.19B
The multi-year forecast shows a bullish trajectory, beginning with a 2026 avg of $66.46 and a 2027 avg of $104.40, rising through 2028 ($107.76) and 2029 ($119.45), and reaching a 2030 avg of $140.17. By 2040 the forecast envisions an avg of $530.54 and by 2050 an avg of $880.01, with the respective max values of $1,032.19 and $1,920.35. Across these years, the forecasted ROI grows from 0% in 2026 to 110.9% in 2030, 698.3% in 2040, and 1224.1% in 2050, with overall bullish sentiment persisting across the horizon.
These figures reflect estimated paths rather than guarantees, and actual results may vary.
Tap a question to reveal the answer.
The forecast shows an avg price of $140.17 in 2030, with a min of $95.28 and a max of $223.56, and an ROI of 110.9%.
Forecasts show a bullish trajectory across multiple years, with rising average prices (e.g., $66.46 in 2026, $104.40 in 2027, $140.17 in 2030) and increasing ROI (up to 110.9% by 2030 and higher later years), though these are estimates and not guarantees.
Yes. The 2027 forecast lists an avg of $104.40, and the path continues higher in subsequent years (e.g., 2029 avg $119.45 and 2030 avg $140.17).
The 2040 forecast shows an avg of $530.54, with a min of $279.24 and a max of $1,032.19, and an ROI of 698.3%.
The current price is $66.46 and the market cap is $3.16B.
MBX Biosciences, Inc. Community Discussion
0Share your MBX Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.